the role of firm characteristics in pharmaceutical product launches margaret k kyle august 4 2005 abstract this paper examines determinants new since 1980 g7 nations using discrete time hazard models despite obvious incentive to amortize large sunk costs drug development over many markets entry occurs only opportunities results indicate that such as domestic status and experience local market are important explaining addition also interaction between innovating target country is a critical component profitability drugs 1 5 times more likely be launched share border or language company s headquarters even for multinational firms effect competition depends on both potential entrant incumbents entrants prefer compete with although an industry ubiquitous licensing low transportation specific match quality conditions remains determinant fuqua school business duke university mkyle edu
